Mankind Pharma's Founders Map Growth Plan After Pulling Off Major IPO
Juneja brothers eye a spot among India's top three sales leaders by expanding into bigger cities and selling more expensive medications.
Stay updated with breaking news from Biotec Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juneja brothers eye a spot among India's top three sales leaders by expanding into bigger cities and selling more expensive medications.
India Resurgence Fund (IndiaRF), a special situations investment platform sponsored by Piramal Enterprises and Bain Capital Credit, is in talks with its limited partners (LPs) to raise its second fund targeting up to $1 billion. The first fund had a corpus of $629 million with main LPs including CPPIB and IFC. The second fund aims to attract commitments from CPPIB and IFC, with a first closing expected by December.
Three months after its debut on the exchanges on May 9, the stock has scaled over 30 percent and analysts say there is room for an upside.
As part of the arrangement, Mankind Pharma Ltd, has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business.
Vaccines and Antineoplastic are new combined entities for Mankind: IQVIA